Urinary podocyte-derived microparticles in youth with type 1 and type 2 diabetes.


Journal

Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777

Informations de publication

Date de publication:
02 2021
Historique:
received: 22 06 2020
accepted: 18 08 2020
pubmed: 11 10 2020
medline: 21 1 2022
entrez: 10 10 2020
Statut: ppublish

Résumé

The release of podocyte-derived microparticles into the urine may reflect early kidney injury in diabetes. We measured the urinary excretion of podocyte-derived microparticles in youth with type 1 and type 2 diabetes, and related the values to blood pressure, renal function and blood glucose levels. Cross-sectional, exploratory analysis of urine samples and clinical data from youth with type 1 (n = 53) and type 2 (n = 50) diabetes was carried out. Urinary podocyte-derived microparticle numbers, measured by flow cytometry, were assessed in relation to measures of blood glucose levels and renal function. Podocyte-derived microparticle excretion (MPE) normalised to urinary creatinine (MP/UCr) was higher in type 1 vs type 2 diabetes (median [IQR] MP/UCr: 7.88 [8.97] vs 1.84 [8.62]; p < 0.0001), despite the type 2 diabetes group having higher blood pressure (systolic blood pressure, median [range]: 124 [110-154] vs 114 [94-143] mmHg) and higher proportions of microalbuminuria (44.0% vs 13.2%), but shorter time since diabetes diagnosis (median [range]: 1.2 [0.0-7.0] vs 6.4 [2.0-13.9] years), than the type 1 diabetes cohort. MPE in youth with type 1 diabetes was associated with blood glucose (p = 0.01) and eGFR (p = 0.03) but not HbA Significant associations between podocyte MPE, blood glucose levels and eGFR were observed in youth with type 1 diabetes but not in those with type 2 diabetes, notwithstanding increased renal pathology in the type 2 diabetes cohort. These findings suggest that podocyte injury differs in the two diabetes cohorts. Graphical abstract.

Identifiants

pubmed: 33037887
doi: 10.1007/s00125-020-05297-z
pii: 10.1007/s00125-020-05297-z
doi:

Substances chimiques

Blood Glucose 0
Glycated Hemoglobin A 0
hemoglobin A1c protein, human 0
Creatinine AYI8EX34EU

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

469-475

Subventions

Organisme : Canadian Institute of Health Research Operating Grant
ID : MOP-343810,

Commentaires et corrections

Type : ErratumIn

Références

Fioretto P, Mauer M (2007) Histopathology of diabetic nephropathy. Semin Nephrol 27(2):195–207. https://doi.org/10.1016/j.semnephrol.2007.01.012
doi: 10.1016/j.semnephrol.2007.01.012 pubmed: 17418688 pmcid: 2746982
Susztak K, Raff AC, Schiffer M, Bottinger EP (2006) Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55(1):225–233
doi: 10.2337/diabetes.55.01.06.db05-0894
Shah R, Patel T, Freedman JE (2018) Circulating extracellular vesicles in human disease. N Engl J Med 379(10):958–966. https://doi.org/10.1056/NEJMra1704286
doi: 10.1056/NEJMra1704286 pubmed: 30184457
Burger D, Thibodeau JF, Holterman CE, Burns KD, Touyz RM, Kennedy CR (2014) Urinary podocyte microparticles identify prealbuminuric diabetic glomerular injury. J Am Soc Nephrol 25(7):1401–1407. https://doi.org/10.1681/ASN.2013070763
doi: 10.1681/ASN.2013070763 pubmed: 24676640 pmcid: 4073432
Lytvyn Y, Xiao F, Kennedy CR et al (2017) Assessment of urinary microparticles in normotensive patients with type 1 diabetes. Diabetologia 60(3):581–584. https://doi.org/10.1007/s00125-016-4190-2
doi: 10.1007/s00125-016-4190-2 pubmed: 28004150
Dart AB, Martens PJ, Rigatto C, Brownell MD, Dean HJ, Sellers EA (2014) Earlier onset of complications in youth with type 2 diabetes. Diabetes Care 37(2):436–443. https://doi.org/10.2337/dc13-0954
doi: 10.2337/dc13-0954 pubmed: 24130346
Har RL, Reich HN, Scholey JW et al (2014) The urinary cytokine/chemokine signature of renal hyperfiltration in adolescents with type 1 diabetes. PLoS One 9(11):e111131. https://doi.org/10.1371/journal.pone.0111131
doi: 10.1371/journal.pone.0111131 pubmed: 25392936 pmcid: 4230911
Dart AB, Wicklow BA, Sellers EA et al (2014) The Improving Renal Complications in Adolescents With Type 2 Diabetes Through the REsearch (iCARE) Cohort Study: rationale and protocol. Can J Diabetes 38(5):349–355. https://doi.org/10.1016/j.jcjd.2014.07.224
doi: 10.1016/j.jcjd.2014.07.224 pubmed: 25284698
Dart AB, McGavock J, Sharma A, Chateau D, Schwartz GJ, Blydt-Hansen T (2019) Estimating glomerular filtration rate in youth with obesity and type 2 diabetes: the iCARE study equation. Pediatr Nephrol. https://doi.org/10.3390/genes10110921
Flynn JT, Kaelber DC, Baker-Smith CM et al (2017) Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics 140(3). https://doi.org/10.1542/peds.2017-1904
Pagtalunan ME, Miller PL, Jumping-Eagle S et al (1997) Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99(2):342–348. https://doi.org/10.1172/JCI119163
doi: 10.1172/JCI119163 pubmed: 9006003 pmcid: 507802
Toyoda M, Najafian B, Kim Y, Caramori ML, Mauer M (2007) Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes 56(8):2155–2160. https://doi.org/10.2337/db07-0019
doi: 10.2337/db07-0019 pubmed: 17536064
Raile K, Galler A, Hofer S et al (2007) Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 30(10):2523–2528. https://doi.org/10.2337/dc07-0282
doi: 10.2337/dc07-0282 pubmed: 17630266
Hokke S, Arias N, Armitage JA et al (2016) Maternal glucose intolerance reduces offspring nephron endowment and increases glomerular volume in adult offspring. Diabetes Metab Res Rev 32(8):816–826. https://doi.org/10.1002/dmrr.2805
doi: 10.1002/dmrr.2805 pubmed: 27037899
Sellers EA, Blydt-Hansen TD, Dean HJ, Gibson IW, Birk PE, Ogborn M (2009) Macroalbuminuria and renal pathology in First Nation youth with type 2 diabetes. Diabetes Care 32(5):786–790. https://doi.org/10.2337/dc08-1828
doi: 10.2337/dc08-1828 pubmed: 19228860 pmcid: 2671101
Dalla Vestra M, Saller A, Bortoloso E, Mauer M, Fioretto P (2000) Structural involvement in type 1 and type 2 diabetic nephropathy. Diabetes Metab 26(Suppl 4):8–14
pubmed: 10922968
Perkins BA, Bebu I, de Boer IH et al (2019) Risk factors for kidney disease in type 1 diabetes. Diabetes Care 42(5):883–890. https://doi.org/10.2337/dc18-2062
doi: 10.2337/dc18-2062 pubmed: 30833370 pmcid: 6489116
Vallon V, Komers R (2011) Pathophysiology of the diabetic kidney. Compr Physiol 1(3):1175–1232. https://doi.org/10.1002/cphy.c100049
doi: 10.1002/cphy.c100049 pubmed: 23733640 pmcid: 6029262

Auteurs

Katie M Sullivan (KM)

Renal Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. KatieMarie.Sullivan@pennmedicine.upenn.edu.
Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada. KatieMarie.Sullivan@pennmedicine.upenn.edu.

James Scholey (J)

Department of Medicine, University of Toronto, Toronto, ON, Canada.
University Health Network, University of Toronto, Toronto, ON, Canada.

Rahim Moineddin (R)

Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada.

Etienne Sochett (E)

Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Brandy Wicklow (B)

Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada.
Diabetes Research Envisioned and Accomplished in Manitoba (DREAM), Children's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada.

Yesmino Elia (Y)

Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Feng Xiao (F)

Kidney Research Centre, Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.

Thalia Mederios (T)

Kidney Research Centre, Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.

Pusha Sadi (P)

Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada.
Diabetes Research Envisioned and Accomplished in Manitoba (DREAM), Children's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada.

Dylan Burger (D)

Kidney Research Centre, Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.

Farid H Mahmud (FH)

Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Alison B Dart (AB)

Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada.
Diabetes Research Envisioned and Accomplished in Manitoba (DREAM), Children's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH